- For Researchers
- For Biospecimen Contributors
- For Patients
- Human Biospecimens
ZURICH, Switzerland, March 13, 2018 – iSpecimen Director of Marketing Jeff Goldman and partner Science Exchange will co-present today, March 13, at the ProcureCon Europe Pharma Conference in Switzerland. The presentation will demonstrate how iSpecimen’s digital marketplace addresses challenges along the research supply chain, and share industry perspectives on biobanking and procurement.
Since the event’s inception in 1999, the annual ProcureCon Pharma Chttp://www.ispecimen.com/for-researchers/marketplace-for-researchers/onference has become one of the world’s leading international events supporting the procurement field. By showcasing case studies that demonstrate process innovation, new tools, technologies and cutting-edge strategy, its more than 5,000 senior-level executives will be equipped with practical steps on how to better integrate and connect disparate services along the procurement chain.
Goldman’s session on the iSpecimen Marketplace will delve into challenges and solutions in biospecimen procurement that are fulfilling the needs of medical researchers who need high-quality samples – including tissue, biofluids and cells – in precision medicine initiatives.
ProcureCon Pharma will take place from March 13-15th in Zurich, Switzerland.
Headquartered in Lexington, MA, iSpecimen is the marketplace for human biospecimens, providing researchers with the specimens they need from the patients they want. The privately held company has developed the Marketplace, an online platform connecting healthcare organizations that have access to patients and specimens with the scientists who need them. Proprietary, cloud-based technology enables researchers to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. Researchers easily and compliantly gain access to specimens to drive scientific discovery. Partner sites gain an opportunity to contribute to biomedical discovery as well as their bottom line. And ultimately, healthcare advances for all. For more information about iSpecimen, please visit www.ispecimen.com